Skip to main content
. 2024 Sep 4;16:196. doi: 10.1186/s13195-024-01519-3

Table 2.

Description of the study sample – NPS and lifelong mental activities

Overall (n = 87) Cerebral amyloid angiopathy (n = 69) NC (n = 18) p-value (p < 0.05) group analysis p-value subgroup analysis*
ADAS-NC
ADAS-NC9 total number 1 (0–6) 2 (0–6) 0 (0–1) < 0.001
ADAS-NC9 total severity 2 (0–11) 3 (0–11) 0 (0–2) < 0.001

GDS-SF

No depression, n (%)

Minor depressive disorder, n (%)

Major depressive disorder, n (%)

n = 85

56 (65.88)

26 (30.58)

3 (3.52)

n = 67

38 (56.71)

26 (38.80)

3 (4.47)

n = 18

18 (100)

0 (0)

0 (0)

0.001

p < 0.0083

< 0.001

0.002

0.374

LEQ
LEQ YA education 16.50 (7.96) 15.68 (8.20) 19.64 (6.18) 0.009
LEQ YA activities 19.18 (3.93) 19.03 (3.84) 19.76 (4.34) 0.797
LEQ YA total 36.49 (10.10) 35.47 (10.42) 40.39 (7.87) 0.012
LEQ ML occupation 61.58 (22.75) 59.51 (22.79) 69.52 (21.34) 0.098
LEQ ML activities 16.78 (3.63) 16.43 (3.61) 18.11 (3.49) 0.047
LEQ ML total 34.34 (8.68) 32.90 (8.25) 39.84 (8.28) 0.003
LEQ LL specific activities 18.71 (5.00) 17.50 (4.59) 23.35 (3.72) < 0.001
LEQ LL nonspecific activities 14.58 (3.03) 13.93 (2.80) 17.05 (2.64) < 0.001
LEQ LL total 22.39 (5.32) 21.35 (5.20) 26.40 (3.71) < 0.001
LEQ total (cognitive reserve) 93.02 (18.63) 89.47 (18.28) 106.63 (13.08) < 0.001

Note: Values are mean (standard deviation) or median (range) unless otherwise noted. Significant p-values are marked bold. p-values are based on chi-square or Fisher’s exact test (if any cell number was < 5) for categorical variables, and the Mann-Whitney U test for continuous variables. *p-value subgroup analysis is based on post-hoc chi-square testing for multiple comparisons. NPS: neuropsychiatric symptoms. ADAS-NC9: Alzheimer’s Disease Assessment Scale subscale noncognitive with nine items. GDS-SF: Geriatric Depression Scale-Short Form. LEQ: Lifetime of Experiences Questionnaire. YA: young adult. ML: mid-life. LL: late-life